Chutima Talabnin

488 total citations
31 papers, 382 citations indexed

About

Chutima Talabnin is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Chutima Talabnin has authored 31 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 17 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Chutima Talabnin's work include Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers), Glycosylation and Glycoproteins Research (7 papers) and Bone Tissue Engineering Materials (4 papers). Chutima Talabnin is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers), Glycosylation and Glycoproteins Research (7 papers) and Bone Tissue Engineering Materials (4 papers). Chutima Talabnin collaborates with scholars based in Thailand, United States and United Kingdom. Chutima Talabnin's co-authors include Wipa Suginta, Han Choe, Sopit Wongkham, Kyung Jin Lee, Narong Khuntikeo, Mayumi Ishihara, Mark Murphy, Griangsak Eumkeb, Parastoo Azadi and Chawalit Pairojkul and has published in prestigious journals such as Applied Microbiology and Biotechnology, Journal of Materials Science and Physics in Medicine and Biology.

In The Last Decade

Chutima Talabnin

29 papers receiving 379 citations

Peers

Chutima Talabnin
Yang Ke China
Liwei Hu China
Xiaofang Xu China
Wenchang Guo United States
Wanle Hu China
Jorge Luis María Ruiz Brazil
Muhammad Massarwa Israel
Andrew Harbottle United Kingdom
Xiang Jiao China
Chunjie Wen China
Yang Ke China
Chutima Talabnin
Citations per year, relative to Chutima Talabnin Chutima Talabnin (= 1×) peers Yang Ke

Countries citing papers authored by Chutima Talabnin

Since Specialization
Citations

This map shows the geographic impact of Chutima Talabnin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chutima Talabnin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chutima Talabnin more than expected).

Fields of papers citing papers by Chutima Talabnin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chutima Talabnin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chutima Talabnin. The network helps show where Chutima Talabnin may publish in the future.

Co-authorship network of co-authors of Chutima Talabnin

This figure shows the co-authorship network connecting the top 25 collaborators of Chutima Talabnin. A scholar is included among the top collaborators of Chutima Talabnin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chutima Talabnin. Chutima Talabnin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asavaritikrai, Pundit, et al.. (2025). In vitro properties of four benign meningioma cells derived from WHO grade 1 meningiomas. Human Cell. 38(3). 84–84.
2.
3.
4.
Sokol, Olga, Chutima Talabnin, C. Kobdaj, et al.. (2022). 3D high resolution clonogenic survival measurement of xrs-5 cells in low-dose region of carbon ion plans. International Journal of Radiation Biology. 99(3). 488–498.
5.
Talabnin, Chutima, et al.. (2022). Piperlongumine and bortezomib synergically inhibit cholangiocarcinoma via ER stress–induced cell death. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(1). 109–120. 7 indexed citations
6.
7.
Talabnin, Chutima, et al.. (2021). Gymnema inodorum (Lour.) Decne. Extract Alleviates Oxidative Stress and Inflammatory Mediators Produced by RAW264.7 Macrophages. Oxidative Medicine and Cellular Longevity. 2021(1). 8658314–8658314. 26 indexed citations
8.
Talabnin, Chutima, et al.. (2021). Influence of polyacrylic acid (PAA)/Na 2 HPO 4 mixture on biphasic calcium phosphate cement: Enhancing strength and cell viability. International Journal of Applied Ceramic Technology. 18(4). 1365–1378. 5 indexed citations
9.
Sokol, Olga, Julia Wiedemann, Walter Tinganelli, et al.. (2020). Validation of a pseudo-3D phantom for radiobiological treatment plan verifications. Physics in Medicine and Biology. 65(22). 225039–225039. 1 indexed citations
10.
Talabnin, Chutima, Lukana Ngiwsara, Yepy H. Rustam, et al.. (2020). Effect of Expression of Human Glucosylceramidase 2 Isoforms on Lipid Profiles in COS-7 Cells. Metabolites. 10(12). 488–488. 6 indexed citations
11.
Talabnin, Chutima, et al.. (2020). Intracellular ROS Scavenging and Anti‐Inflammatory Activities of Oroxylum indicum Kurz (L.) Extract in LPS plus IFN‐γ‐Activated RAW264.7 Macrophages. Evidence-based Complementary and Alternative Medicine. 2020(1). 7436920–7436920. 21 indexed citations
12.
Suginta, Wipa, et al.. (2017). Piperlongumine induces G2/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway. APOPTOSIS. 22(11). 1473–1484. 70 indexed citations
13.
Talabnin, Chutima, et al.. (2017). Increased expression of the high‑mannose M6N2 and NeuAc3H3N3M3N2F tri‑antennary N‑glycans in cholangiocarcinoma. Oncology Letters. 15(1). 1030–1036. 18 indexed citations
14.
Silsirivanit, Atit, Sopit Wongkham, Banchob Sripa, et al.. (2016). YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma. Tumor Biology. 37(7). 9451–9463. 21 indexed citations
15.
16.
Vaeteewoottacharn, Kulthida, Wunchana Seubwai, Chutima Talabnin, et al.. (2016). Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity. Oncology Reports. 36(3). 1435–1446. 27 indexed citations
17.
Talabnin, Chutima, et al.. (2016). Differential Expression of O-glycoprotein Glycans in Cholangiocarcinoma Cell Lines. Asian Pacific Journal of Cancer Prevention. 17(2). 691–695. 7 indexed citations
18.
Namwat, Nisana, Watcharin Loilome, Anchalee Techasen, et al.. (2013). Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis. Tumor Biology. 34(3). 1579–1588. 60 indexed citations
19.
Bhudhisawasdi, Vajarabhongsa, et al.. (2012). Cholangiocarcinoma: Experience of Srinagarind Hospital. Srinagarind Medical Journal (SMJ) - ศรีนครินทร์เวชสาร. 27(3). 331–339. 11 indexed citations
20.
Talabnin, Chutima, et al.. (2012). Evaluation of postoperative adjuvant chemotherapy for intrahepatic cholangiocarcinoma patients undergoing R1 and R2 resections.. PubMed. 13 Suppl. 169–74. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yang Ke Breakdown of academic impact, for papers by Liwei Hu Breakdown of academic impact, for papers by Xiaofang Xu Breakdown of academic impact, for papers by Wenchang Guo Breakdown of academic impact, for papers by Wanle Hu Breakdown of academic impact, for papers by Jorge Luis María Ruiz Breakdown of academic impact, for papers by Muhammad Massarwa Breakdown of academic impact, for papers by Andrew Harbottle Breakdown of academic impact, for papers by Xiang Jiao Breakdown of academic impact, for papers by Chunjie Wen
Rankless by CCL
2026